相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sharmila Makhija et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
Richard P. Baum et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
Teemu T. Junttila et al.
CANCER CELL (2009)
Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Werner Scheuer et al.
CANCER RESEARCH (2009)
Engineered affinity proteins-Generation and applications
Caroline Gronwall et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line
Lina Ekerljung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
Sang Bong Lee et al.
CLINICAL CANCER RESEARCH (2008)
Interaction of Alzheimer's Aβ peptide with an engineered binding protein -: Thermodynamics and kinetics of coupled folding-binding
Wolfgang Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
Wolfgang Hoyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule
Vladimir Tolmachev et al.
CANCER RESEARCH (2007)
Structural basis for molecular recognition in an Affibody:: Affibody complex
Christofer Lendel et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Conformational stabilization of an engineered binding protein
Elisabet Wahlberg et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Characterization of the dynamics of biomacromolecules using rotating-frame spin relaxation NMR spectroscopy
Arthur G. Palmer et al.
CHEMICAL REVIEWS (2006)
Tumor Imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova et al.
CANCER RESEARCH (2006)
Thermodynamics of folding, stabilization, and binding in an engineered protein-protein complex
V Dincbas-Renqvist et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Selection and characterization of HER2/neu-binding affibody ligands
M Wikman et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
An affibody in complex with a target protein:: Structure and coupled folding
E Wahlberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
Studying excited states of proteins by NMR spectroscopy
FAA Mulder et al.
NATURE STRUCTURAL BIOLOGY (2001)
The ErbB signaling network: receptor heterodimerization in development and cancer
MA Olayioye et al.
EMBO JOURNAL (2000)
分享论文
